PHGN34 Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Koninklijke Philips N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €136.50 |
52 Week High | €148.00 |
52 Week Low | €89.00 |
Beta | 0.78 |
1 Month Change | 35.78% |
3 Month Change | 27.67% |
1 Year Change | 30.57% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 44.84% |
Recent News & Updates
Recent updates
Shareholder Returns
PHGN34 | BR Medical Equipment | BR Market | |
---|---|---|---|
7D | 26.1% | 0.5% | 0.4% |
1Y | 30.6% | -1.7% | 14.6% |
Return vs Industry: PHGN34 exceeded the BR Medical Equipment industry which returned -2.6% over the past year.
Return vs Market: PHGN34 exceeded the BR Market which returned 16.7% over the past year.
Price Volatility
PHGN34 volatility | |
---|---|
PHGN34 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.6% |
Market Average Movement | 4.7% |
10% most volatile stocks in BR Market | 8.9% |
10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: PHGN34's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine PHGN34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1891 | 69,656 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
PHGN34 fundamental statistics | |
---|---|
Market cap | R$124.10b |
Earnings (TTM) | -R$4.36b |
Revenue (TTM) | R$99.50b |
1.2x
P/S Ratio-28.5x
P/E RatioIs PHGN34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHGN34 income statement (TTM) | |
---|---|
Revenue | €18.14b |
Cost of Revenue | €10.63b |
Gross Profit | €7.51b |
Other Expenses | €8.30b |
Earnings | -€794.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 29, 2024
Earnings per share (EPS) | -0.88 |
Gross Margin | 41.38% |
Net Profit Margin | -4.38% |
Debt/Equity Ratio | 63.8% |
How did PHGN34 perform over the long term?
See historical performance and comparison